$9.99
0.000.00%
Pre-Market: Jan 17, 4:00 PM EDT
Immunome reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Immunome using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-0.78 | $-0.56 | -39.3 % |
Q2 | 2024-08-12 | $-0.60 | $-0.39 | -53.8 % |
Q1 | 2024-05-14 | $-0.34 | $-0.69 | 50.7 % |
Q4 | 2024-03-28 | $-0.15 | $-0.28 | 46.4 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $2.91M | $2.13M | 36.6 % |
Q2 | 2024-08-12 | $2.36M | $2.55M | -7.29 % |
Q1 | 2024-05-14 | $1.03M | $2.50M | -58.8 % |
Q4 | 2024-03-28 | $3.83M | $2.07M | 84.8 % |
Immunome (IMNM) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.78, which missed the estimate of $-0.56.
The Actual Revenue was $2.9M, which beat the estimate of $2.1M.
Browse earnings estimates, EPS, and revenue on all stocks.